Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sklyuev (Novosibirsk, Russian Federation), D. Krasnov (Novosibirsk, Russian Federation), Y. Petrova (Novosibirsk, Russian Federation), E. Myshkova (Novosibirsk, Russian Federation). Safety of the endobronchial valve use in the complex treatment of patients with destructive MDR/XDR TB associated with HIV infection.. 1603

Member's Comments

No comment yet.

Related content which might interest you: Endobronchial valve in complex treatment of patients with destructive pulmonary TB/HIV co-infection Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks Year: 2016 Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Efficacy of endobronchial valve placement in complex treatment of MDR TB – clinical case Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008 Endobronchial valve application in tuberculosis patients with low treatment adherence Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Efficacy of different preoperational treatment in patients with destructive pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005 Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Imaging patterns of disseminating forms of pulmonary TB associated with end-stage HIV infection Source: Eur Respir J 2006; 28: Suppl. 50, 507s Year: 2006